We are live on ! Find out more
Polen Capital Management

Polen Capital Management Portfolio holdings

AUM $11.6B
1-Year Est. Return 8.03%
This Fund
S&P 500
This Quarter Est. Return
+6.01%
1 Year Est. Return
+8.03%
3 Year Est. Return
+64.37%
5 Year Est. Return
+58.48%
10 Year Est. Return
+511%
AUM
$30.8B
AUM Growth
-$1.78B
Cap. Flow
-$2.86B
Cap. Flow %
-9.3%
Top 10 Hldgs %
56.46%
Holding
292
New
52
Increased
67
Reduced
112
Closed
60

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$1.38B
2
NVDA icon
NVIDIA
NVDA
+$1.09B
3
SNPS icon
Synopsys
SNPS
+$591M
4
BSX icon
Boston Scientific
BSX
+$580M
5
INTU icon
Intuit
INTU
+$477M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$966M
2
ORCL icon
Oracle
ORCL
+$686M
3
AMZN icon
Amazon
AMZN
+$606M
4
ADBE icon
Adobe
ADBE
+$538M
5
SHOP icon
Shopify
SHOP
+$492M

Sector Composition

Rank Sector Weight
1 Technology 46.94%
2 Financials 16.15%
3 Healthcare 15.52%
4 Consumer Discretionary 12.62%
5 Communication Services 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPY icon
126
Oppenheimer Holdings
OPY
$1.24B
$1.21M ﹤0.01%
16,343
-1,639
-9% -$119K
EMBJ
127
Embraer S.A. ADS
EMBJ
$13.4B
$1.2M ﹤0.01%
19,858
-2,426
-11% -$137K
ESQ icon
128
Esquire Financial Holdings
ESQ
$1.36B
$1.19M ﹤0.01%
11,709
+17
+0.1% +$1.68K
VCTR icon
129
Victory Capital Holdings
VCTR
$7.42B
$1.17M ﹤0.01%
18,135
-3,251
-15% -$223K
IRS
130
IRSA Inversiones y Representaciones
IRS
$1.27B
$1.13M ﹤0.01%
95,306
-68,292
-42% -$975K
LQDT icon
131
Liquidity Services
LQDT
$1.31B
$1.12M ﹤0.01%
40,688
+60
+0.1% +$1.54K
STRL icon
132
Sterling Infrastructure
STRL
$15.2B
$1.11M ﹤0.01%
3,273
-296
-8% -$84K
PLPC icon
133
Preformed Line Products
PLPC
$2B
$1.11M ﹤0.01%
5,660
+8
+0.1% +$1.41K
XERS icon
134
Xeris Biopharma Holdings
XERS
$1.58B
$1.08M ﹤0.01%
133,191
+197
+0.1% +$1.31K
GH icon
135
Guardant Health
GH
$22.9B
$1.08M ﹤0.01%
17,271
+7,088
+70% +$386K
MRUS
136
DELISTED
Merus
MRUS
$1.08M ﹤0.01%
11,460
+5,626
+96% +$366K
TDUP icon
137
ThredUp
TDUP
$361M
$1.04M ﹤0.01%
110,370
+57,381
+108% +$543K
CW icon
138
Curtiss-Wright
CW
$22.9B
$1.04M ﹤0.01%
1,909
-186
-9% -$91.6K
ARLO icon
139
Arlo Technologies
ARLO
$1.41B
$1.03M ﹤0.01%
60,486
+11,296
+23% +$192K
PBI icon
140
Pitney Bowes
PBI
$2.33B
$1.01M ﹤0.01%
88,476
+20,254
+30% +$236K
GRAL
141
GRAIL Inc
GRAL
$3.55B
$986K ﹤0.01%
16,673
-5,265
-24% -$201K
REAX icon
142
Real REMAX Group Inc. Common Stock
REAX
$580M
$981K ﹤0.01%
23,463
-16,670
-42% -$753K
MIRM icon
143
Mirum Pharmaceuticals
MIRM
$6.01B
$978K ﹤0.01%
13,339
-2,168
-14% -$138K
NRG icon
144
NRG Energy
NRG
$24.4B
$973K ﹤0.01%
6,009
-123
-2% -$19.2K
YOU icon
145
Clear Secure
YOU
$4.55B
$964K ﹤0.01%
+28,871
New +$957K
SION
146
Sionna Therapeutics
SION
$279M
$919K ﹤0.01%
31,258
+14,283
+84% +$311K
LTH icon
147
Life Time Group Holdings
LTH
$10B
$904K ﹤0.01%
32,740
-16,403
-33% -$468K
CRM icon
148
Salesforce
CRM
$168B
$889K ﹤0.01%
3,752
-1,237
-25% -$312K
ASTE icon
149
Astec Industries
ASTE
$1.01B
$872K ﹤0.01%
18,108
+7,152
+65% +$313K
ELF icon
150
e.l.f. Beauty
ELF
$6.31B
$858K ﹤0.01%
6,478
+2,614
+68% +$322K

Similar funds

Polen Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Polen Capital Management held 292 positions worth $30.8B, down 5.5% from $32.6B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Polen Capital Management withdrew a net $2.86B in Q3 2025, closing 60 positions and reducing 112 holdings. Its most notable exit was Novo Nordisk, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 39% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Polen Capital Management opened a new position in Broadcom worth $1.48B.

  • Polen Capital Management's largest Q3 2025 buy was Broadcom: 4,485,854 shares worth $1.48B.
  • Polen Capital Management added most to NVIDIA in Q3 2025, an estimated $1.09B increase.
  • Polen Capital Management's biggest Q3 2025 reduction was Thermo Fisher Scientific, cutting an estimated $966M.
  • Polen Capital Management fully exited Novo Nordisk in Q3 2025, selling an estimated $12.3M.
  • Polen Capital Management's ten largest holdings make up 56% of its $30.8B portfolio in Q3 2025.
  • Polen Capital Management opened 52 new positions and closed 60 in Q3 2025.
  • Polen Capital Management's portfolio value fell 5.5% quarter-over-quarter to $30.8B.

Based on Polen Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.